-0.15%
3.85%
0.74%
-11.94%
-14.75%
-31.02%
0.82%

Company Description

Amplifon S.p.A. retails hearing care products and services that help people rediscover various emotions of sound.The company offers ampli-easy, ampli-mini, ampli-connect, and ampli-energy hearing devices.It also provides fitting of customized products.


As of March 18, 2022, the company operated a network of approximately 9,200 points of sale in 25 countries and 5 continents.The company also sells its products through 1,350 franchisees.It has operations in Europe, the Middle East, Africa, the United States, Asia, and Oceania.


The company was founded in 1950 and is headquartered in Milan, Italy.

Market Data

Last Price 25.89
Change Percentage -0.15%
Open 25.98
Previous Close 25.93
Market Cap ( Millions) 5838
Volume 597828
Year High 35.14
Year Low 22.89
M A 50 25.03
M A 200 28.49

Financial Ratios

FCF Yield 4.59%
Dividend Yield 1.12%
ROE 13.91%
Debt / Equity 153.33%
Net Debt / EBIDTA 277.39%
Price To Book 5.24
Price Earnings Ratio 37.5
Price To FCF 21.76
Price To sales 2.47
EV / EBITDA 13.24

Business Breakdown

Expected Mid-Term Growth

Segment nΒ°1 -> Hearing Solutions

Expected Growth : 8.9 %

What the company do ?

Hearing Solutions from Amplifon S.p.A. provides personalized hearing care services and products, including hearing aids, testing, and counseling, to improve communication and quality of life.

Why we expect these perspectives ?

Amplifon's 8.9% growth in Hearing Solutions is driven by increasing demand for hearing aids, expansion into emerging markets, and strategic acquisitions. Additionally, the company's focus on innovative products, such as AI-powered hearing aids, and its strong distribution network contribute to its growth momentum.

Segment nΒ°2 -> Services

Expected Growth : 8.37 %

What the company do ?

Amplifon S.p.A. offers a range of services including hearing tests, hearing aid fitting, and audiological care, providing personalized solutions for hearing loss and tinnitus.

Why we expect these perspectives ?

Amplifon's 8.37% growth is driven by increasing demand for hearing solutions, expansion into emerging markets, and strategic acquisitions. The company's focus on innovative products and services, such as artificial intelligence-powered hearing aids, also contributes to growth. Additionally, Amplifon's strong distribution network and partnerships with healthcare providers enable the company to reach a wider customer base.

Amplifon S.P.A. Products

Product Range What is it ?
Hearing Aids Amplifon offers a wide range of hearing aids from leading manufacturers, including Phonak, Oticon, and Widex. These devices are designed to improve hearing and communication for individuals with hearing loss.
Hearing Tests and Diagnostics Amplifon provides comprehensive hearing tests and diagnostics to identify hearing loss and determine the best course of treatment.
Audiology Services Amplifon's team of audiologists provides personalized audiology services, including hearing aid fittings, adjustments, and maintenance.
Hearing Protection Amplifon offers custom-made hearing protection solutions for individuals working in noisy environments or participating in loud recreational activities.
Tinnitus Management Amplifon provides tinnitus management solutions, including sound therapy and counseling, to help individuals cope with tinnitus symptoms.

Amplifon S.p.A.'s Porter Forces

The threat of substitutes for Amplifon S.p.A. is medium due to the presence of alternative products and services in the hearing care industry.

The bargaining power of customers for Amplifon S.p.A. is low due to the company's strong brand reputation and customer loyalty.

The bargaining power of suppliers for Amplifon S.p.A. is medium due to the presence of multiple suppliers in the market.

The threat of new entrants for Amplifon S.p.A. is low due to the high barriers to entry in the hearing care industry.

The intensity of rivalry for Amplifon S.p.A. is high due to the presence of several competitors in the hearing care industry.

Capital Structure

Value
Debt Weight 50.88%
Debt Cost 3.96%
Equity Weight 49.12%
Equity Cost 7.68%
WACC 5.79%
Leverage 103.57%

Historical Valuation

Price/Earnings Ratio

Margin Valuation

Peers Valuation

Competitors

Company Rational
TECN.SW Tecan Group AG provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business …
YPSN.SW Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and …
EKTA-B.ST Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac …
AFX.DE Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. …
CTEC.L ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting …

Peers Metrics

DCF BETA

Parameters

Short Term Growth
Short term Time
Long-Term Growth
WACC
Target Price
25.89$
Current Price
25.89$
Potential
-0.00%

Expected Cash-Flows

Scoring Insights

Peers Group Analysis

πŸ₯‡

Elekta Logo
Elekta
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

πŸ₯ˆ

Ypsomed Logo
Ypsomed
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

πŸ₯‰

ConvaTec Logo
ConvaTec
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

4

Amplifon Logo
Amplifon
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

5

Tecan Logo
Tecan
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->

6

Carl Zeiss Meditec Logo
Carl Zeiss Meditec
A-Score # N/A

Value:# N/A

Growth: # N/A

Quality: # N/A

Yield: # N/A

Momentum: # N/A

Volatility: # N/A

1-Year Total Return ->